Overview

MTX Discontinuation and Vaccine Response

Status:
Completed

Trial end date:
2016-08-01

Target enrollment:

Participant gender:

Summary

To investigate whether a short term discontinuation of methotrexate (MTX) will improve the vaccination efficacy to seasonal influenza vaccination without deteriorating RA disease activity in a randomized clinical trial.

Phase:

Phase 4

Details

Lead Sponsor:

Seoul National University Hospital

Treatments:

Methotrexate
Vaccines